|
HS Code |
448746 |
| Chemical Name | 2-Acetamido-6-Chlorobenzoic Acid |
| Cas Number | 15307-28-7 |
| Molecular Formula | C9H8ClNO3 |
| Molecular Weight | 213.62 |
| Appearance | White to off-white solid |
| Melting Point | 220-224°C |
| Solubility | Slightly soluble in water |
| Purity | Typically ≥98% |
| Synonyms | 6-Chloro-2-acetamidobenzoic acid |
| Storage Temperature | 2-8°C |
| Inchi Key | KFOXVLMHZCEBMP-UHFFFAOYSA-N |
As an accredited 2-Acetamido-6-Chlorobenzoic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a sealed amber glass bottle containing 25 grams of 2-Acetamido-6-Chlorobenzoic Acid, labeled with safety and identification details. |
| Shipping | **Shipping Description:** 2-Acetamido-6-Chlorobenzoic Acid is shipped in tightly sealed containers to prevent contamination and moisture exposure. The packaging complies with chemical safety guidelines, clearly labeled with hazard information. During transit, it is handled as a non-hazardous solid but stored away from incompatible substances and extreme temperatures to maintain product integrity. |
| Storage | 2-Acetamido-6-Chlorobenzoic Acid should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from direct sunlight and sources of ignition. Avoid exposure to moisture and incompatible substances such as strong oxidizing agents. Store at room temperature, and ensure that the container is clearly labeled to prevent accidental misuse or contamination. |
Applications of 2-Acetamido-6-Chlorobenzoic Acid in Industrial Manufacturing2-Acetamido-6-Chlorobenzoic Acid serves as a key specialty intermediate that supports advanced synthesis routes in select industries. As the direct manufacturer, we supply this raw material to global partners whose final applications demand precise control of process quality, compliance to industry protocols, and tailored integration into established compound production flows. Below we outline the principal industrial segments where this compound is used for proven, large-scale outputs, detailing specific end-uses and considerations at each production stage. 1. Pharmaceutical Intermediate for Cephalosporin Antibiotic SynthesisThis raw material is primarily introduced as a vital building block during the synthesis of certain cephalosporin antibiotics, especially those with extended-spectrum activity. In commercial pharmaceutical manufacturing, it functions as a protected aromatic acid and undergoes further functionalization in multi-step organic reactions. Its use directly impacts the downstream quality of beta-lactam core structures, thus making it integral to API development for anti-infective therapies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Synthesis Intermediate for Fungicide ProductionSelective agrochemical manufacturers employ this intermediate in the creation of chlorinated benzamide-based fungicides. The compound’s unique aromatic structure aligns with the developmental chemistry required for highly regulated crop protection agents, and its controlled reactions facilitate substitution patterns not readily achievable through direct chlorination of other benzoic acid precursors. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Chemical Intermediate for Dyes and Pigment ManufacturingLeading specialty chemical producers utilize this compound in the tailored synthesis of high-performance azo and anthraquinone dyes. Its selectively substituted benzene ring introduces halogen and amide functionalities that modify pigment binding affinity and color fastness, especially for fibres subjected to rigorous industrial dyeing procedures. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Veterinary Drug Active Substance SynthesisWithin the animal health sector, this material supports the production of select veterinary cephalosporins and related pharmaceutical agents. Its function as an intermediate ensures lot-to-lot consistency for veterinary preparations, where supply chain monitoring and cross-contamination prevention are prioritized during bulk pharma compound manufacturing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Precursor for Specialty Chemical Synthesis in Research and DevelopmentAdvanced material development laboratories and specialty synthesis facilities incorporate this compound as a customizable aromatic platform for small-series synthesis projects. Its reactive positions enable introduction of additional functional groups, supporting both scale-up trials and pilot runs for innovative molecules not yet produced on bulk scale. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-Acetamido-6-Chlorobenzoic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every day at our facility, dozens of raw materials move through reactors, filtration setups, and crystallizers—the tools of our trade. One compound that consistently comes off our lines is 2-Acetamido-6-Chlorobenzoic Acid, also referred to in research and industry as a specialty aromatic carboxylic acid. Our production team has worked closely with process engineers to ensure the output hits the specifications demanded by downstream users in pharmaceutical research, intermediates development, and certain fine chemical syntheses.
The typical batch leaves our reactors as a crystalline powder, white to light beige in color, with a chemical structure defined by an acetamido group at the second position and a chlorine at the sixth position of the benzoic acid ring. We analyze our product for purity, which regularly exceeds 99%. Impurity profiles, including related chlorinated and acetamido isomers, remain closely monitored—a demand that’s come directly from conversations with lab managers and process chemists we supply.
Our experience tells us sloppy synthesis leads to unpredictable outcomes downstream. Early on, we competed with lower-cost imports that traded on price, but we watched customers struggle with variable impurity content, inconsistent melting points, and poor solubility behavior. Several of our regular clients, frustrated with unwanted side reactions in their research, requested tighter controls on residual solvents, especially concerning chlorinated byproducts and acetic acid traces. This feedback pushed us to invest in analytical hardware and robust SOPs for every batch.
Purity and batch consistency drive almost every discussion we have about this compound. Quality checks—including HPLC, NMR, and mass spectrometry—don’t just generate paperwork, they let us guarantee a product that doesn’t cause unexpected results in the hands of a research chemist. In one instance, a customer synthesizing a novel amide found inferior grade 2-acetamido-6-chlorobenzoic acid left behind trace contaminants that affected their biological assays. After we shared batch analysis and discussed their protocols, they switched to our higher grade product and measured a dramatic drop in background interference.
Our batches hit a melting range between 195 and 200°C. Water content usually sits below 0.2%, and residual solvents, such as DMF or acetic acid, are tightly regulated—numbers we confirm by GC. We pay close attention not just to overall purity, but to isomeric and oxidative degradation products. Storage conditions in our plant are optimized for stability, but once the material ships, our technical team regularly discusses best practices with our customers: sealed containers, controlled humidity, away from strong oxidizers. This repetitive feedback loop between our lab and the field helps us tweak process variables to meet what end-users actually need on the bench or in the plant.
Pharmaceutical chemists are the most frequent users of 2-Acetamido-6-Chlorobenzoic Acid. Our compound often goes into the early-stage synthesis of novel active pharmaceutical ingredients, as well as reference libraries for drug screening. Process chemistry teams tell us they value predictability—they need to scale up without surprises. Stable reactivity, consistent melting point, and low levels of colored impurities can save weeks of troubleshooting. In several specialty segments, like agrochemical development and pigment research, the compound’s halogenated aromatic backbone gives unique reactivity and physical properties that are hard to replicate.
We also see this acid as a building block for more complex amides and heterocyclic systems. One global peptide synthesis group we supply reported that the acetamido group—delivered intact and unhydrolyzed—plays a crucial role in forming robust linkages under surprisingly harsh coupling conditions. This isn’t possible if residual moisture or hydrolyzed impurities sneak in, so we take great care during drying and packaging.
The chemistry community works with a spectrum of benzoic acid derivatives, but subtle differences can create major changes in downstream processes. For instance, 2-acetamidobenzoic acid (also known as N-acetylanthranilic acid) lacks the chlorine substituent and serves as a gentler reactant. In contrast, our 2-acetamido-6-chlorobenzoic acid introduces an ortho-chloro group, which can activate or deactivate the aromatic ring for electrophilic or nucleophilic substitution—something our customers in medicinal chemistry take advantage of when designing next-generation molecules.
A couple of process developers in pilot plants have told us how the electron-withdrawing nature of the chlorine atom provides unique selectivity in multi-step syntheses, especially when managing oxidative transformations or selective halogen exchange. This specificity is not just a matter of academic interest; these subtle electronic effects can govern yield, purity, and scalability. For users considering alternatives, either for patent circumvention or cost, we explain that swapping out the 6-chloro for a hydrogen may seem like an incremental change, but in synthesis everything hinges on the details. Our experience bears this out: in certain Suzuki couplings or amidation reactions, reaction rates and byproduct profiles shift dramatically.
Our plant started synthesizing this compound with glass-lined reactors, manually charged with acetanilide, chlorobenzoic acid, and acid chlorides under precise temperature control. Today, with solvent recovery and in-line filtration, we cut down on waste and control exothermic runs much more smoothly. We’ve learned that temperature ramp rates make a difference for color and filterability, so we monitor every batch reaction with tight process control.
Most issues—like dark-colored byproducts or sub-par crystallinity—have been solved through operator vigilance and feedback from end users who flagged our early attempts as substandard. One large-scale synth used to face bottlenecks during work-up due to insoluble material, but shifting our drafting sequence and crystallization solvent fixed this. By iterating on these small but critical details, we have managed to make a product that customers say drops right into their flow chemistry setups or batch reactors with minimal rework.
We don’t just load drums onto pallets and consider the job done. Shipping regulations related to chlorinated aromatics require certain labeling and packaging; nobody wants delays at customs over paperwork or specification disputes. Over time, we’ve taken feedback from import managers and compliance teams to ensure documentation matches requirements and full traceability gets documented—right down to batch-level impurity data. This has helped several pharmaceutical supply chains stay smooth, even amid sudden audits and regulatory scrutiny.
Even the small details—humidity in shipping containers, inner linings of packaging, or secondary contamination risks—matter for a product like this. Our technical support team regularly fields questions from new users on storage, shelf life, and handling minor material clumping. Sometimes there’s not a universal answer: someone in a humid tropic will face different challenges than a user in a dry climate, so we stay in touch after delivery and document lessons as we go.
Scale brings new challenges. As production rose, our waste streams shifted—mainly, increased volumes of chlorinated process water and acetic acid residues. These couldn’t be ignored any longer; regulatory demands at the local and international level now demand waste minimization and safe treatment. We invested in solvent recovery and neutralization beds not only to meet compliance but also to control operating costs. When major off-takers began asking for documented “greener” alternatives, we experimented with batch parameter tweaks that cut the solvent load by a measurable margin without compromising product quality.
There is no magic bullet to waste, but by collaborating with other local manufacturers, we’ve formed a consortium to share best practices around waste reduction and byproduct valorization. This includes on-site solvent recycling and periodic third-party audits—a move which over time has both cut corners off our utility bills and helped make compliance audits smoother.
Manufacturing chemistry is never static. Our journey with 2-acetamido-6-chlorobenzoic acid has seen quality issues, processing delays, raw material price jumps, and occasionally hard-to-predict batch failures tied to minute changes in upstream feedstock. These problems are not unique to this compound, but the tight tolerances and regulatory pressure in the pharmaceutical market make any glitch costly. Staffing continuous improvement teams and maintaining a robust relationship with our upstream suppliers helps prevent surprises.
Supply chain disruptions do not always announce themselves. For a spell, an upstream supplier of acetanilide shut down for maintenance, causing tightness in the market and some delay for our customers. Rather than source from unvetted suppliers, we kept communication clear and transparent—sharing updates, adjusting schedules, and providing technical documentation so our downstream clients could plan around the shortfall. This open-book approach, learned over years, builds trust and typically turns short-term roadblocks into repeat business, coming from users who prefer reliability over cost-cutting.
A handful of customers in regulated spaces have requested additional documentation to support their internal audits. We work directly with their regulatory teams, providing signed batch certificates, impurity breakdowns, and even historical deviation records. Being open about lab findings—good or bad—has forged stronger customer relationships. These users show us that manufacturing goes far beyond pushing a good-looking powder out the door.
No process stays perfect forever. Our R&D group continues to investigate alternative synthetic routes, including lower temperature coupling methods and greener chlorination steps. There is interest in continuous flow chemistry, which could reduce batch times and decrease waste. Feedback from our largest customers has encouraged us to focus on shelf life extension, which ties directly to better stability formulations during packaging.
Recent conversations in the industry have focused on process intensification—reducing the number of synthetic steps and implementing in-line analytical monitoring. We believe this will cut down on batch-to-batch deviations and reduce the overall energy footprint. Our team is launching pilot runs exploring these new process technologies, hoping to deliver even tighter impurity profiles and lower environmental impact.
Chemists doing hands-on synthesis have little patience for fluff. They want reliable materials, straightforward data, and real communication from suppliers. Our experience making 2-acetamido-6-chlorobenzoic acid has shown us that successful supply doesn’t end with the shipping manifest. It continues through tech support calls, shared troubleshooting, and honest conversations about what is and isn’t working. This feedback loop, built over years with polymer, pharma, and pesticide development groups, keeps us improving batch after batch.
Recently, an early-stage biotech firm flagged a minor issue: lots from a particular production window had slightly altered color. Our QA team dug into archived batch records, traced back to a subtle pH variation in a precursor step, and quickly adjusted the process. This collaborative approach meant current and future batches went out with improved specs, and the customer responded by placing an extended order—proof that open lines and a willingness to fix issues yield real results.
Alternatives with minor changes—whether swapping the position of the acetamido group, removing the chloride, or using an unsubstituted benzoic acid—do not always translate in real-world experiments. Colleagues in pharma mention attempts to replace our product with lower-cost 2-acetamidobenzoic acid; in many cases, downstream conversion steps fail, yields suffer, or isolation becomes a bottleneck. The ortho-chloro group’s unique electronic influence precisely tunes reactivity, offering a window to otherwise challenging synthetic targets.
Direct side-by-side testing in our own applications lab has demonstrated the difference. Using 2-acetamido-6-chlorobenzoic acid as a precursor in multi-step aminolysis consistently produces higher yields and purities versus more basic benzoic acids. Not every customer needs this edge, but for those scaling up complex syntheses, this difference can push a project from pilot scale into full production.
2-Acetamido-6-chlorobenzoic acid is not just a chemical registry number—making it involves careful raw material selection, process optimization, real-world troubleshooting, and close customer dialogue. Each drum tells the story of operators making temperature calls, lab staff troubleshooting signals, and support teams juggling paperwork and compliance. Industry remains driven by stories like these, and from our side, it is the steady feedback and evolving challenges that keep us innovating and investing.
As downstream uses diversify—from medicinal chemistry to materials science—users will continue to demand ever-tighter specifications, greener credentials, and a manufacturer who understands the product not just as numbers on a sheet, but through the lens of hands-on experience. We see our future in this space built on trust, technical rigor, and a willingness to share what success—and the occasional setback—looks like behind the scenes.